If we have selected the wrong experience for you, please change it above.
Context is king: Moving from vision to execution with metadata (Part 2)
Building the AI-powered metadata architecture for your research data
In the age of AI, metadata is more critical than ever. Metadata provides the necessary context that AI models require to successfully interpret and utilize an organization’s proprietary data. Part two of our series will explore key considerations for metadata architecture solutions in life sciences' research and development (R&D) organizations as they strive to realize their digitally connected lab-of-the-future vision.
Key takeaways:
- Four design principles to consider for any AI-integrated metadata architecture
- Core capabilities to look for in agentic investment and scientific data management workflows
- Organizational pillars necessary to implement AI-forward lab changes
- Lab of the Future solutions powered by Deloitte and Amazon Web Services
From vision to execution
In part one of this series, we established why metadata is the critical foundation for an AI-ready research organization, and the three interconnected challenges of capturing, standardizing and integrating automated metadata and scientific data management.
The takeaway from the article was clear: AI alone cannot yield a sustainable competitive advantage. It’s the proprietary data that biopharmaceutical organizations possess that provides a leg up. But without proper context and management, this data is ultimately useless for AI.
Part two of this series addresses the issues organizations often face when choosing and implementing laboratory workflows. First, we define the design principles for a target-state metadata architecture and the core capabilities that make the vision technically achievable. Second, we examine the strategic, governance and organizational foundations without which even the most sophisticated technology will likely underdeliver. Our goal for examining both areas is to help better define what an AI-integrated lab of the future looks like for life sciences organizations.
Designing the target-state architecture for metadata management
A target-state metadata architecture is a foundational rethink of how experimental context is captured, structured and made available. The governing insight is this: metadata capture must become a transparent byproduct of scientific work, harvested from the tools scientists already use, without requiring separate effort. Below are four key design principles for comprehensive R&D data management:
- User-first, transparent by design
Metadata quality is directly correlated with ease of capture. The metadata architecture must serve scientists, data teams and AI practitioners transparently. It should harvest context as a byproduct of scientific action, never as a separate task. - Open and cloud native with data interoperability
Pharmaceutical R&D environments are among the most complex technology landscapes in any industry. The architecture must scale with modalities, sites, experiments and instruments, and integrate natively with electronic lab notebook (ELN), laboratory information management systems (LIMS), and data platforms through open application programming interfaces (APIs) (not proprietary connectors). - Agentic and AI-enabled
Metadata schemas evolve constantly, and critical context lives in unstructured content that rules-based systems cannot parse. AI agents must be embedded within workflows to extract, maintain and enrich metadata continuously. This helps ensure the system gets smarter as science evolves, and not degraded. - Interoperable and standards-driven
The ability to connect data at scale to enable cross-functional insights is dependent on building data products that are interoperable. To achieve this, ontologies should be used to enforce a controlled vocabulary across key metadata fields to a common standard. Additional design principles (i.e., API-driven integrations) can help companies better leverage this data by simplifying integration with downstream systems for reuse.
Core capabilities for delivering modern metadata solutions
With the above design principles as the guiding framework, targeted investments will unlock value across each of the key phases of the experimental life cycle. In the figure below, we present how agentic workflows can provide near-term impact for organizations. We highlight steps primed for such investments (denoted by robot icon), which then link to specific solution descriptions below.
Step 1: Design and planning: Automate metadata capture during experimental design and planning
Agentic experimental design and planning assistant
Captures essential elements such as study intent, protocol parameters, and hypotheses during experimental design. Using voice or text input, intelligent agents record scientific rationale in real time, surface related prior studies, and connect seamlessly to planning resources, including instrument booking, reagent registration, and plate map generators. The potential result is that cross-study relationships and experimental context are captured proactively.
Semantic metadata extraction from unstructured scientific content
A large proportion of experimental context—hypotheses, protocol rationale, deviations, and observations—exists as free text in ELN entries, protocol PDFs, and instrument notes that traditional pipelines cannot parse. Agents based on large language models extract structured metadata fields from these sources without requiring scientists to fill in forms, enriching captured metadata without increasing scientific workload. Extraction confidence scoring and human-in-the-loop review triggers for low-confidence fields are nonnegotiable design requirements because incorrect metadata is worse than missing metadata.
Step 2: Experiment execution: Create real-time metadata capture during experiment execution
Instrument data mover, monitor and control tower
A centralized resource for managing automated migration of raw instrument data to cloud, this step is triggered by experimental completion events rather than manual action. A monitoring layer tracks the progression of data files through event-driven parsing, standardization and annotation pipelines. This helps capture instrument metadata, acquisition parameters and environmental variables at point of generation. Real-time visibility into processing status means data-quality issues are surfaced immediately, not discovered weeks later.
Agentic parser development and maintenance framework
Instrument manufacturers regularly update output file formats, and each update has the potential to silently break existing data pipelines. These errors are typically discovered downstream, long after the fact. This framework detects changes to instrument files, then autonomously drafts, tests and deploys updated parser code. The result is that instrument metadata capture remains uninterrupted as the instrument landscape evolves. Additionally, parsers should funnel metadata into standardized, vendor-agnostic models, such as Allotrope Simple Model, to reduce the complexity of parsed results.
Step 3: Data products and analysis: Build fully contextualized, ready-to-use data products
Metadata repository
Before any capture, extraction or analytics capability can deliver value, there must be a central, cloud-native metadata repository: a structured, versioned, query-able store that acts as the single source of truth for experimental context across studies, modalities, programs and time. Built on FAIR data principles and API-first design, it enables any downstream system—like an AI training pipeline, a regulatory submission tool, a portfolio analytics platform—to consume metadata without bespoke integrations. This requires a tiered schema that allows metadata to be layered onto experiments. Using stable, persistent identifiers to link key entities and metadata domains—including samples, instruments, reagents, protocols and results—enables unambiguous cross-study linkage regardless of schema evolution.
Dynamic annotation of data products
To take full advantage of the metadata infrastructure previously described, organizations also need to invest in tools to apply metadata to their datasets. Metadata is not a static entity: data models will need to evolve to adapt to advances in technology and scientific understanding. Robust pipelines for evaluating the annotation quality for existing data products are integrated into the source of truth (the metadata repository) to automatically update these products as necessary for preserving the utility of organizational data.
Research assistant for natural language data navigation
Surfaces experimental datasets through natural language queries, leveraging the rich metadata layer to enable discovery without knowledge of underlying schemas or database structures. A researcher can ask for all screening results for a specific target and cell line in plain language and receive a curated, contextualized result set, making FAIR data tangible at the point of scientific need. This is the downstream payoff of upstream metadata investment, delivered directly into the hands of researchers.
More than a technology problem: Anchoring metadata transformation in strategy, governance and people
The technology capabilities described above are available today. The harder problem—and where many metadata modernization efforts often stall—is organizational. In answer to that challenge, three foundational strategic pillars determine whether a metadata transformation delivers lasting value.
Pillar 1: Anchor on business value and focus the transformation
The most effective framing is to identify high-value scientific workflows—assay development, in-vivo studies, or a specific discovery modality—and fix metadata end to end within those workflows first. This approach can deliver demonstrable returns faster than a broad platform rollout, builds organizational evidence that the investment is worth making, and creates the proof points needed to secure leadership buy-in for enterprise-scale transformation. Securing leadership buy-in requires explicitly connecting metadata modernization efforts to the AI-driven transformations that many R&D leaders are already accountable for. Framed as a technical project, metadata modernization will likely compete poorly for investment against programs with a clearer near-term return. Framed as the foundational enabler of AI strategy, it becomes a strategic priority.
Pillar 2: Institutionalize governance and adopt a data as a product model
Leading organizations are moving toward data as a product strategy in R&D. Building data using a product mindset involves separating data into functional domains (i.e., assay results, sample information, etc.) with a named owner, a defined schema, a quality roadmap, and measurable key performance indicators for completeness, lineage coverage, and reuse rate. The data product mindset requires a fundamental shift in how organizations treat metadata. This view includes designating metadata required infrastructure maintained by multifunctional groups within the company, including IT, business and scientific stakeholders.
In practice, this requires:
- Shared, controlled vocabularies and ontologies that create a common language for cross-study analysis without manual harmonization.
- Consistent standards across ELN, LIMS, and other knowledge registries so metadata created in one system is available to all consumers without reentry or transformation.
- Visible, quality dashboards that surface completeness scores, coverage gaps, and reuse metrics to domain owners to help make metadata quality transparent. This will help boost the useability of the data products and drive higher quality standards by owners.
Pillar 3: Elevate people, culture and change enablement
Improving metadata quality ultimately requires scientists to buy into the process. The frictionless, agentic capture systems described earlier can serve as a catalyst for improvement. But embracing a cultural shift—one that changes from viewing metadata as tedious overhead to recognizing it as a vital scientific asset—requires a strategic plan.
Concretely, this means organizations need to make three changes by:
- Demonstrating how metadata enables traceability and reproducibility in scientists' own prior work by surfacing examples where missing context from their own experiments has required re-execution or limited interpretability.
- Making data discovery visibly easier as metadata quality improves, so scientists experience the return on their capture investment directly, through faster access to relevant prior datasets.
- Recognizing and incentivizing metadata quality as a component of scientific practice, not treating it as an IT compliance task peripheral to research productivity.
The compounding return on metadata investment
In the next decade of pharmaceutical R&D, the most advanced algorithm may matter less than the metadata and data infrastructure organizations build to feed it. The architecture, capabilities and operating model are available today. Deloitte, in collaboration with Amazon Web Services (AWS), has developed the Lab of the Future solution: a suite of cloud-native accelerators built on the principles described above to help organizations move from vision to execution—while remaining flexible enough to address their specific needs.
But that’s only part of the equation. Beyond the tools, it’s the organizational will to treat metadata not as a project but as a persistent operating principle, one embraced at every level of the scientific process, that is necessary to realize your lab of the future today.
